Cilastatin

CHEMBL766 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

358.5 g/mol

LogP

-1.0

Phase

4

A competitive inhibitor of the renal enzyme dehydropeptidase-I that degrades imipenem in the kidney, used exclusively in combination with imipenem to prevent renal inactivation and nephrotoxicity of the antibiotic. It has no intrinsic antibacterial activity of its own. The combination dramatically improves the pharmacokinetic profile and safety of imipenem.

分子量

358.5000 g/mol

LogP

-1.00

TPSA

155.00 Å²

リピンスキーの五則

適合

治療領域

Infectious Disease Ovarian Cancer Hematology Oncology Obesity Tuberculosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O

InChI

InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1

Molecular Formula

C16H26N2O5S

HBD / HBA

4 / 7

回転可能結合数

11

重原子数

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A competitive inhibitor of the renal enzyme dehydropeptidase-I that degrades imipenem in the kidney, used exclusively in combination with imipenem to prevent renal inactivation and nephrotoxicity of the antibiotic. It has no intrinsic antibacterial activity of its own. The combination dramatically improves the pharmacokinetic profile and safety of imipenem.

Yes, Cilastatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL766. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6435415. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Cilastatin PillFYIで

構造

クイックデータ

分子式: C16H26N2O5S
同義語: 3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.